Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 2
2013 1
2014 1
2015 2
2016 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Serruys PW, et al. N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18. N Engl J Med. 2009. PMID: 19228612 Free article. Clinical Trial.
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV, Magnuson EA, Wang K, Serruys PW, Kappetein AP, Mohr FW, Cohen DJ; SYNTAX Investigators. Arnold SV, et al. Circ Cardiovasc Qual Outcomes. 2012 May;5(3):267-75. doi: 10.1161/CIRCOUTCOMES.111.964585. Epub 2012 Apr 10. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22496114 Clinical Trial.
The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery Trial and Registry.
Parasca CA, Head SJ, Mohr FW, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Colombo A, Dawkins KD, Serruys PW, Kappetein AP; SYNTAX Investigators. Parasca CA, et al. J Thorac Cardiovasc Surg. 2015 Sep;150(3):597-606.e2. doi: 10.1016/j.jtcvs.2015.05.010. Epub 2015 May 8. J Thorac Cardiovasc Surg. 2015. PMID: 26055439 Free article. Clinical Trial.
Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, Dawkins KD, Mack MJ; SYNTAX Investigators. Kappetein AP, et al. Eur J Cardiothorac Surg. 2013 May;43(5):1006-13. doi: 10.1093/ejcts/ezt017. Epub 2013 Feb 14. Eur J Cardiothorac Surg. 2013. PMID: 23413014 Clinical Trial.
Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
Parasca CA, Head SJ, Milojevic M, Mack MJ, Serruys PW, Morice MC, Mohr FW, Feldman TE, Colombo A, Dawkins KD, Holmes DR Jr, Kappetein PA; SYNTAX Investigators. Parasca CA, et al. JACC Cardiovasc Interv. 2016 Dec 26;9(24):2493-2507. doi: 10.1016/j.jcin.2016.09.044. JACC Cardiovasc Interv. 2016. PMID: 28007201 Free article. Clinical Trial.
Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry.
Head SJ, Parasca CA, Mack MJ, Mohr FW, Morice MC, Holmes DR Jr, Feldman TE, Dawkins KD, Colombo A, Serruys PW, Kappetein AP; SYNTAX Investigators. Head SJ, et al. Eur J Cardiothorac Surg. 2015 Apr;47(4):685-95. doi: 10.1093/ejcts/ezu197. Epub 2014 May 12. Eur J Cardiothorac Surg. 2015. PMID: 24819358